🇺🇸 FDA
Patent

US 11014892

5HT1F receptor agonists and mitochondrial biogenesis

granted A61KA61K45/06A61P

Quick answer

US patent 11014892 (5HT1F receptor agonists and mitochondrial biogenesis) held by United States Government as represented by the Department of Veterans Affairs expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K45/06, A61P, A61P13/12